Revenue Recognition Segment revenue by major payor (Tables)

9 Months Ended

Sep. 30, 2022

Disaggregation of Revenue [Table Text Block]

The following tables summarize the Company's segment revenues by primary payor source:


	Three months ended September 30, 2022						Three months ended September 30, 2021
	U.S. dialysis		Other — Ancillary services		Consolidated		U.S. dialysis		Other — Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	1,535,680	$		$	1,535,680	$	1,543,819	$		$	1,543,819
Medicaid and Managed Medicaid	193,853				193,853		203,169				203,169
Other government	86,852		116,084		202,936		82,624		113,260		195,884
Commercial	880,812		56,170		936,982		862,218		54,857		917,075
Other revenues:
Medicare and Medicare Advantage			78,345		78,345				77,277		77,277
Medicaid and Managed Medicaid			412		412				377		377
Commercial			6,484		6,484				7,164		7,164
Other(1)	6,056		10,903		16,959		6,216		9,442		15,658
Eliminations of intersegment revenues	(22,957)				(22,957)		(22,104)				(22,104)
Total	$	2,680,296	$	268,398	$	2,948,694	$	2,675,942	$	262,377	$	2,938,319

(1)Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.


	Nine months ended September 30, 2022						Nine months ended September 30, 2021
	U.S. dialysis		Other - Ancillary services		Consolidated		U.S. dialysis		Other - Ancillary services		Consolidated
Dialysis patient service revenues:
Medicare and Medicare Advantage	$	4,529,300	$		$	4,529,300	$	4,586,278	$		$	4,586,278
Medicaid and Managed Medicaid	570,380				570,380		585,053				585,053
Other government	253,731		349,633		603,364		245,125		338,553		583,678
Commercial	2,570,054		164,302		2,734,356		2,528,499		157,172		2,685,671
Other revenues:
Medicare and Medicare Advantage			255,204		255,204				243,085		243,085
Medicaid and Managed Medicaid			1,181		1,181				981		981
Commercial			16,029		16,029				14,387		14,387
Other(1)	18,124		29,584		47,708		19,308		31,107		50,415
Eliminations of intersegment revenues	(64,516)				(64,516)		(70,424)		(4,294)		(74,718)
Total	$	7,877,073	$	815,933	$	8,693,006	$	7,893,839	$	780,991	$	8,674,830

(1) Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.